Skip to main content
10x Genomics, Inc. (TXG)
NASDAQ: TXG · IEX Real-Time Price · USD
27.59
+0.69 (2.57%)
At close: Apr 26, 2024, 4:00 PM
27.25
-0.34 (-1.23%)
After-hours: Apr 26, 2024, 6:00 PM EDT

10x Genomics Revenue

In the year 2023, 10x Genomics had annual revenue of $618.73M with 19.81% growth. Revenue in the quarter ending December 31, 2023 was $183.98M with 17.76% year-over-year growth.

Revenue (ttm)
$618.73M
Revenue Growth
+19.81%
P/S Ratio
5.34
Revenue / Employee
$491,443
Employees
1,259
Market Cap
3.30B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.76B
Fortrea Holdings 3.11B
Surgery Partners 2.74B
Evolent Health 1.96B
Progyny 1.09B
Sotera Health Company 1.05B
SpringWorks Therapeutics 5.45M
Crinetics Pharmaceuticals 4.01M
Revenue Rankings

TXG News

More News